COVID-19 Funding Opportunities
These are funding opportunities available to medical researchers specific to the Coronavirus Disease (COVID-19).
| Organization(s) | Title | Notice Number | Expiration Date | Activity Code(s) |
| NICHD, NIAAA, NIDA, NINDS, OBSSR, ORWH | Notice of Special Interest (NOSI) – Administrative Supplements for Research of Emerging and Existing Issues of COVID-19 Related to the Health and Well-Being of Women, Children and Individuals with Physical and/or Intellectual Disabilities | NOT-HD-22-003 | 6/6/2024 | 333 |
| NICHD, NIDA, NIEHS, NINDS, OBSSR, ORWH | Notice of Special Interest (NOSI) – Emerging and Existing Issues of Coronavirus Disease 2019 (COVID-19) Research Related to the Health and Well-Being of Women, Children and Individuals with Physical and/or Intellectual Disabilities | NOT-HD-22-002 | 6/6/2024 | R01, R21 |
| NCATS, NIAMS, NICHD, NIDCR, NIGMS, NIMHD, OBSSR, ORWH | Limited Competition: Clinical and Translational Science Award (CTSA) Program: Collaborative and Innovative Acceleration Award (UG3/UH3 Clinical Trial Optional) | PAR-22-167 | 10/18/2024 | UG3/UH3 |
| NIMH, NIAAA, NIEHS, ORWH | Accelerating the Pace of Child Health Research Using Existing Data from the Adolescent Brain Cognitive Development (ABCD) Study (R21-Clinical Trial Not Allowed) | PAR-22-138 | 5/8/2025 | R21 |
| NIMH, NIAAA, NIEHS, ORWH | Accelerating the Pace of Child Health Research Using Existing Data from the Adolescent Brain Cognitive Development (ABCD) Study (R01-Clinical Trial Not Allowed) | PAR-22-137 | 5/8/2025 | R01 |
| NHLBI | Notice of Special Interest (NOSI): Enhancing Research on Deciphering Mechanisms of COVID-19-Associated Coagulopathy | NOT-HL-23-080 | 7/6/2025 | R01 |
| NIH, NCATS, NCCIH, NCI, NHGRI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDCD, NIDDK, NIEHS, NIGMS, NIMH, NIMHD, NINR, NLM, ORWH, OSC | Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement – Clinical Trial Optional) | PA-20-135 | 9/8/2025 | 333 |
| NIDA, NCCIH, NIA, NIAAA | Notice of Special Interest (NOSI) HEAL Initiative: Workforce Interventions to Improve Addiction Care Quality and Patient Outcomes | NOT-DA-23-008 | 9/8/2025 | R61/R33 |
| NHLBI | Notice of Special Interest (NOSI): Studies of Cellular/Molecular Pathobiological Mechanisms of Lung Diseases Using Human 3-Dimensional Cellular Systems (R01) | NOT-HL-22-030 | 9/8/2025 | R01 |
| NIAAA | Notice of Special Interest: Administrative Supplements and Urgent Competitive Revisions on Coronavirus Disease 2019 (COVID-19) within the Mission of NIAAA | NOT-AA-22-002 | 05/08/24 | 333 |
| NICHD | Notice of Special Interest (NOSI): Promoting Vaccine Access, Acceptance and Uptake among Children, Adolescents, Pregnant and Lactating Women, and Persons with Disabilities | NOT-HD-21-038 | 05/08/24 | R03, R21 |
| NIAID, NIMH, NIDA | Notice of Special Interest (NOSI) HIV/AIDS in the Era of COVID-19: When Pandemics Collide | NOT-AI-21-057 | 05/08/24 | R01, R21 |
| NHLBI | Notice of Special Interest (NOSI): The Influence of Host Resilience on Heterogeneity of Acute Respiratory Distress Syndrome/Acute Lung Injury (ARDS/ALI) | NOT-HL-20-814 | 07/06/24 | R01 |
| NCATS | Notice of Special Interest (NOSI): Availability of Emergency Competitive Revisions for the Clinical and Translational Science Award (CTSA) Program to Address COVID-19 Public Health Needs | NOT-TR-21-022 | 08/17/24 | 333 |
| NCATS | Notice of Special Interest (NOSI): Administrative Supplements for the Clinical and Translational Science Award (CTSA) Program to Address COVID-19 Public Health Needs | NOT-TR-21-017 | 08/17/24 | 333 |
| NIDA | Notice of Special Interest (NOSI): Telehealth Strategies for Individuals with HIV and Substance Use Disorders | NOT-DA-21-019 | 09/08/24 | R01, R03, R21 |
| NIDA | Notice of Special Interest (NOSI): Medical Consequences of Smoking and Vaping Drugs of Abuse in Individuals with HIV and COVID-19 | NOT-DA-21-017 | 09/08/24 | R01, R03, R21 |
| NIDA | Notice of Special Interest (NOSI): Long-Term Neurocognitive Consequences of COVID-19 in Individuals Living with HIV and Substance Use Disorders | NOT-DA-21-018 | 09/08/24 | R01, R03, R21 |
| NIDA | Notice of Special Interest (NOSI): Effects of smoking and vaping on the risk and outcome of COVID-19 infection | NOT-DA-21-011 | 09/08/24 | R01, R03, R21 |
| NIDA | RESCINDED – Notice of Special Interest (NOSI): Effects of smoking and vaping on the risk and outcome of COVID-19 infection | NOT-DA-20-084 | 09/08/24 | R01, R03, R21 |
| NIMH | Notice of Special Interest (NOSI): COVID-19 Pandemic Mental Health Research | NOT-MH-22-100 | 01/08/25 | R21, R34, R01 |
| NHLBI | Notice of Special Interest (NOSI): Research on barriers to care and risk of HIV-associated comorbidities among vulnerable population groups | NOT-HL-22-010 | 05/08/25 | R01 |
| NHLBI, NICHD, NIAID | Notice of Special Interest (NOSI) Pediatric COVID-19 and Respiratory Viral Co-infection | NOT-HL-22-004 | 09/08/25 | R01, R21 |
| NIH, NCATS, NCCIH, NCI, NHGRI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDCD, NIDDK, NIEHS, NIGMS, NIMH, NIMHD, NINR, NLM, ORWH, OSC | Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement – Clinical Trial Optional) | PA-20-135 | 09/08/25 | 333 |
| Office of Biomedical Advanced Research and Development Authority (BARDA) ǀ Broad Agency Announcement (BAA) | BARDA expanded its standard broad agency announcement (BAA) to accept proposals for advanced development of diagnostics, vaccines, therapeutics and other medical products for use in the current COVID-19 emergency response and future coronavirus outbreaks. | |||
| National Science Foundation (NSF) (NSF) | NSF Rapid Response Research (RAPID) funding mechanism for non-medical, non-clinical-care research that can be used immediately to explore how to model and understand the spread of COVID-19, to inform and educate about the science of virus transmission and prevention, and to encourage the development of processes and actions to address this global challenge. |